The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1186
ISSUE1186
July 5, 2004
Amlodipine/Atorvastatin (Caduet)
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Amlodipine/Atorvastatin (Caduet)
July 5, 2004 (Issue: 1186)
Caduet (Pfizer), a combination of the calcium-channel blocker amlodipine (Norvasc - Pfizer) and the HMG-CoA reductase inhibitor (statin) atorvastatin (Lipitor - Pfizer), is now available in the US. It was approved by the FDA for use in patients with...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.